HOOD RIVER CAPITAL MANAGEMENT LLC – Neurocrine Biosciences, Inc. Transaction History
HOOD RIVER CAPITAL MANAGEMENT LLC portfolio value:
$20.64M
portfolio value
HOOD RIVER CAPITAL MANAGEMENT LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.93% | 3.67K shares | 2.05M | $106.21 | 194.40K |
| Q2 2022 | share | Increase | +5.63% | 10.17K shares | 1.66M | $97.48 | 190.72K |
| Q1 2022 | share | Increase | +2.09% | 3.68K shares | 1.86M | $93.75 | 180.55K |
| Q4 2021 | share | Decrease | -1.03% | -1.84K shares | -2.07M | $84.63 | 176.86K |
| Q3 2021 | share | Increase | 0.00% | 178.71K shares | 17.14M | $95.91 | 178.71K |
| Q2 2020 | share | Decrease | -100.00% | -110.04K shares | -9.52M | $122 | 0 |
| Q1 2020 | share | Increase | 0.00% | 110.04K shares | 9.52M | $86.55 | 110.04K |
| Q2 2017 | share | Decrease | -100.00% | -109.31K shares | -4.73M | $46 | 0 |
| Q1 2017 | share | Decrease | -46.76% | -96.01K shares | -3.21M | $43.3 | 109.31K |
| Q4 2016 | share | Increase | +109.37% | 107.25K shares | 2.98M | $38.7 | 205.32K |
| Q3 2016 | share | Decrease | -29.45% | -40.93K shares | -1.35M | $50.64 | 98.07K |
| Q2 2016 | share | Increase | +2.55% | 3.45K shares | 957K | $45.45 | 139.00K |
| Q1 2016 | share | Increase | 0.00% | 135.55K shares | 5.36M | $39.55 | 135.55K |